Open AccessIn Reply
Author(s) -
Lenihan Daniel J.,
Kowey Peter R.
Publication year - 2014
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2013-0433
Subject(s) - medicine , cardiology , pulmonary hypertension , cardiac dysfunction , intensive care medicine , heart failure
A thorough description of cardiovascular events that might be noted with tyrosine kinase inhibitors would include a discussion of the pulmonary arterial hypertension but this focused review was intentionally limited to the most common cardiac events, including systemic hypertension, left ventricular dysfunction, and QT prolongation.